南芯科技(688484.SH):擬不超1.6億元收購昇生微100%股權
格隆匯1月21日丨南芯科技(688484.SH)公佈,公司擬以現金方式收購珠海昇生微電子有限責任公司(簡稱“昇生微”或“標的公司”或“交易標的”)100%股權,收購對價合計不超過人民幣16,000萬元。
本次交易有利於雙方整合產品、技術、市場及客户、供應鏈等資源,在嵌入式領域發揮協同效益,符合公司發展願景與長期戰略規劃。通過本次交易,公司將整合標的公司在嵌入式芯片設計開發領域的技術能力與研發團隊,有助於加強公司嵌入式芯片的硬件、IP、算法、軟件等的技術優勢。同時,本次交易將擴充公司在端側處理器領域的產品品類,擴大公司與客户的合作範圍。在供應鏈方面,通過與標的公司供應鏈資源整合,發揮規模效應,進一步提升公司及標的公司原材料採購成本優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.